Status:
WITHDRAWN
Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia
Lead Sponsor:
Tongji Hospital
Conditions:
COVID-19
Endotracheal Intubation
Eligibility:
All Genders
18-90 years
Brief Summary
To analyze the intubation with severe covid-19 pneumonia, the infection rate of anesthesiologist after intubation, and summarizes the experience of how to avoid the infection of anesthesiologist and e...
Detailed Description
To analyze the intubation time, intubation condition, intubation process, intubation times and success rate of patients with severe covid-19 pneumonia, the infection rate of anesthesiologist after int...
Eligibility Criteria
Inclusion
- Wuhan residents;
- novel coronavirus pneumonia was found to be characterized by fever and cough. Laboratory tests revealed leukocyte or lymphocyte decrease, chest CT examination showed viral pneumonia changes, and was diagnosed as COVID-19 pneumonia according to the national health and Health Committee's new coronavirus pneumonia diagnosis and treatment plan (trial version fifth Revision).
- Severe and critical patients with covid-19 pneumonia in urgent need of tracheal intubation;
- Sign informed consent.
Exclusion
- Suspected patients with covid-19 pneumonia;
- Patients who need emergency endotracheal intubation due to other causes of respiratory failure;
- The family refused to sign the informed consent.
Key Trial Info
Start Date :
August 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04298814
Start Date
August 7 2020
End Date
December 30 2020
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430000